OpenAlex records 23 works, ~2,779 citations, h-index 14, with peak citation years in 2008β2016 and no primary institution listed β consistent with a researcher who moved through Brigham and Women's Hospital, Dana-Farber, Columbia, and Memorial Sloan Kettering, likely at postdoctoral/staff-scientist stage . The h-index of 14 on 23 papers is respectable but not exceptional; nearly all high-citation output occurred before 2017, with only 3 citations recorded since 2020 β a visible productivity deceleration.
Her two most influential works define stress granule biology: the G3BP1/2 knockout study showing these RNA-binding proteins are essential for stress granule assembly (659 citations, J Cell Biology) , and the angiogenin/tRNA-derived stress-induced RNA study (500 citations, JBC) . In the SMA field she has first-author and review leadership: first-authored the U7 snRNP/histone mRNA paper in Cell Reports (91 citations) and co-authored a widely cited SMA mechanisms review (187 citations) . She also contributed to the Nature paper on intronic polyadenylation inactivating tumor suppressors in leukemia (251 citations) .
Strengths: rigorous molecular/cell biology in elite labs (Anderson, Pellizzoni, Mayr, Abdel-Wahab), multiple first-author mechanistic papers, work in a translational area (SMA) where mechanistic insight fed into combination-therapy strategies including p38 MAPK inhibition. Limitations: citation impact is heavily concentrated in middle-author roles on others' flagship papers; independent PI-level output (a lab of her own) is not evident from the data; post-2017 activity is sparse, so current trajectory is uncertain. BLIND SPOT: authorship position and institutional affiliation alone cannot distinguish technical-contributor versus conceptual-leader roles; no ORCID, grant record, or affiliation metadata are available, so an independent-career assessment is incomplete.
Know what changed, what holds up, and what remains uncertain. Every Friday. No ads.